Search

everythinglearnresearchcommunity

for

Search:↓

Topical finasteride with EGCG or TA improves drug release and dermal uptake, potentially treating hair loss effectively.

Male hormones affect COVID-19 severity and certain drugs targeting these hormones could help reduce the risk.

Certain proteins and their receptors are more active during the growth phase of human hair and could be targeted to treat hair disorders.

SARS-CoV-2, the virus causing COVID-19, can affect all endocrine organs and systems, altering their function and potentially leading to disorders. Factors like diabetes and obesity increase infection risk and severity. Understanding these effects is key for effective treatment.

A woman was the first known case to have both polycystic ovary syndrome and autoimmune polyglandular syndrome type 2, suggesting a need to check for both conditions in similar patients.

The SARS-CoV-2 vaccine may be linked to triggering autoimmune conditions like Alopecia Areata.

Guasha changed rat skin appearance and blood vessels temporarily without affecting certain nerve proteins or fiber structure.

Finasteride irreversibly affects human steroid 5α-reductase 2, providing insight into its catalytic mechanism and disease-related mutations.

The conclusion is that certain genetic factors and blood types may affect COVID-19 severity, but changes in ACE2 and TMPRSS2 genes are not clearly linked to it.

The PTGER2 gene is highly active in Cashmere goat skin and its activity changes with the hair growth cycle.

A new compound shows promise as a topical treatment for hair loss.

Long COVID causes various long-term health issues and needs better awareness and treatment.

Alopecia areata is a common autoimmune disease affecting about 2% of people, causing significant disability and often associated with mental health issues and other autoimmune conditions.

Turning white fat into brown-like fat could help fight obesity and type 2 diabetes.

Korean Red Ginseng has beneficial components that help with stress, immunity, fatigue, memory, blood flow, and disease protection.

Dihydrotestosterone (DHT) stops hair growth in mice by lowering a growth factor important for hair.

The document explains hair biology, the causes of hair loss, and reviews various hair loss treatments.

Vitamin D boosts a specific protein in skin cells linked to hair follicles.

Ruxolitinib may help treat hair loss by reducing inflammation, promoting hair growth signals, and protecting hair follicle immunity.

The document concludes that more research is needed to understand airway repair and to improve tissue engineering for lung treatments.

The research identified and described a gene important for hormone conversion in endangered catfish, which varies in activity during different reproductive stages and after hormone treatment.

A compound from Calophyllum inophyllum L. leaf may help treat non-small cell lung cancer.

Advanced hydrogel systems with therapeutic agents could greatly improve acute and chronic wound treatment.

Surface-modified nanoparticles mainly use non-follicular pathways to enhance skin permeation of ibuprofen and could improve treatment for inflammatory skin diseases.

Blocking JAK/STAT pathways can help treat hair loss from alopecia areata.

Certain substances that block a specific protein help promote hair growth.

COVID-19 might worsen symptoms and progression of benign prostatic hyperplasia, possibly due to inflammation and metabolic disturbances in the prostate gland. More research is needed to confirm this.

Animal models are crucial for learning about hair loss and finding treatments.

Vitamin D made by the skin plays a role in immune defense and skin health, and more research is needed to understand its full effects.

New materials help control stem cell growth and specialization for medical applications.